L. Ingeborgh van Den Born

L. Ingeborgh van Den Born

Auto-generated profile, based on publicly available information

L. Ingeborgh van Den Born

The Rotterdam Eye Hospital, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Ophthalmology
Verified
Journal Article
Closed access
ATAlberta A.H.J. Thiadens
Alberta A.H.J. Thiadens
SRSusanne Roosing
Susanne Roosing
Rob CollinRob Collin
Rob Collin
NMNorka van Moll-Ramirez
Norka van Moll-Ramirez
JLJanneke J.C. van Lith-Verhoeven
Janneke J.C. van Lith-Verhoeven
CKCaroline Klaver
Caroline Klaver

1 December 2013 in Ophthalmology
Verified
Journal Article
Closed access
ASAnna M. Siemiatkowska
Anna M. Siemiatkowska
LBL. Ingeborgh van Den Born
L. Ingeborgh van Den Born
PHP. Martin van Hagen
P. Martin van Hagen
MSMonique Stoffels
Monique Stoffels
KNKornelia Neveling
Kornelia Neveling
Rob CollinRob Collin
Rob Collin

Verified
Journal Article
Open access
PDF file
LDLonneke Duijkers
Lonneke Duijkers
LBL. Ingeborgh Van Den Born
L. Ingeborgh Van Den Born
JNJohn Neidhardt
John Neidhardt
NBNathalie M. Bax
Nathalie M. Bax
LPLaurence H. M. Pierrache
Laurence H. M. Pierrache
Alex GarantoAlex Garanto
Alex Garanto
Leber congenital amaurosis (LCA) is a rare inherited retinal disorder affecting approximately 1:50,000 people worldwide. So far, mutations in 25 genes have been associated with LCA, with CEP290 (encoding the Centrosomal protein of 290 kDa) being the most frequently mutated gene. The most recurrent LCA-causing CEP290 mutation, c.2991+1655A>G, causes the insertion of a pseudoexon into a variable proportion of CEP290 transcripts. We previously demonstrated that antisense oligonucleotides (AONs) have a high therapeutic potential for patients homozygously harbouring this mutation, although to date, it is unclear whether rescuing one single allele is enough to restore CEP290 function. Here, we assessed the AON efficacy at RNA, protein and cellular levels in samples that are compound heterozygous for this mutation, together with a protein-truncating mutation in CEP290. We demonstrate that AONs can efficiently restore splicing and increase protein levels. However, due to a high variability in ciliation among the patient-derived cell lines, the efficacy of the AONs was more difficult to assess at the cellular level. This observation points towards the importance of the severity of the second allele and possibly other genetic variants present in each individual. Overall, AONs seem to be a promising tool to treat CEP290-associated LCA, not only in homozygous but also in compound heterozygous carriers of the c.2991+1655A>G variant.

22 April 2021 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
ZFZeinab Fadaie
Zeinab Fadaie
Laura WhelanLaura Whelan
Laura Whelan
ADAdrian Dockery
Adrian Dockery
CLCatherina H Z Li
Catherina H Z Li
LBL Ingeborgh van Den Born
L Ingeborgh van Den Born
SRSusanne Roosing
Susanne Roosing
Background: Inherited retinal diseases (IRDs) can be caused by variants in >270 genes. The Bardet-Biedl syndrome 1 (BBS1) gene is one of these genes and may be associated with syndromic and non-syndromic autosomal recessive retinitis pigmentosa (RP). Here, we identified a branchpoint variant in BBS1 and assessed its pathogenicity by in vitro functional analysis. Methods: Whole genome sequencing was performed for three unrelated monoallelic BBS1 cases with non-syndromic RP. A fourth case received MGCM 105 gene panel analysis. Functional analysis using a midigene splice assay was performed for the putative pathogenic branchpoint variant in BBS1. After confirmation of its pathogenicity, patients were clinically re-evaluated, including assessment of non-ocular features of Bardet-Biedl syndrome. Results: Clinical assessments of probands showed that all individuals displayed non-syndromic RP with macular involvement. Through detailed variant analysis and prioritisation, two pathogenic variants in BBS1, the most common missense variant, c.1169T>G (p.(Met390Arg)), and a branchpoint variant, c.592-21A>T, were identified. Segregation analysis confirmed that in all families, probands were compound heterozygous for c.1169T>G and c.592-21A>T. Functional analysis of the branchpoint variant revealed a complex splicing defect including exon 8 and exon 7/8 skipping, and partial in-frame deletion of exon 8. Conclusion: A putative severe branchpoint variant in BBS1, together with a mild missense variant, underlies non-syndromic RP in four unrelated individuals. To our knowledge, this is the first report of a pathogenic branchpoint variant in IRDs that results in a complex splice defect. In addition, this research highlights the importance of the analysis of non-coding regions in order to provide a conclusive molecular diagnosis.

19 March 2013 in Ophthalmic Epidemiology
Verified
Journal Article
Closed access
PDF file
ATAlberta A. H. J. Thiadens
Alberta A. H. J. Thiadens
CHCarel B. Hoyng
Carel B. Hoyng
JPJan Roelof Polling
Jan Roelof Polling
RBRiet Bernaerts-Biskop
Riet Bernaerts-Biskop
LBL. Ingeborgh van Den Born
L. Ingeborgh van Den Born
CKCaroline Klaver
Caroline Klaver
Purpose: To determine which color vision test is most appropriate for the identification of cone disorders. Methods: In a clinic-based study, four commonly used color vision tests were compared between patients with cone dystrophy (n = 37), controls with normal visual acuity (n = 35), and controls with low vision (n = 39) and legal blindness (n = 11). Mean outcome measures were specificity, sensitivity, positive predictive value and discriminative accuracy of the Ishihara test, Hardy-Rand-Rittler (HRR) test, and the Lanthony and Farnsworth Panel D-15 tests. Results: In the comparison between cone dystrophy and all controls, sensitivity, specificity and predictive value were highest for the HRR and Ishihara tests. When patients were compared to controls with normal vision, discriminative accuracy was highest for the HRR test (c-statistic for PD-axes 1, for T-axis 0.851). When compared to controls with poor vision, discriminative accuracy was again highest for the HRR test (c-statistic for PD-axes 0.900, for T-axis 0.766), followed by the Lanthony Panel D-15 test (c-statistic for PD-axes 0.880, for T-axis 0.500) and Ishihara test (c-statistic 0.886). Discriminative accuracies of all tests did not further decrease when patients were compared to controls who were legally blind. Conclusions: The HRR, Lanthony Panel D-15 and Ishihara all have a high discriminative accuracy to identify cone disorders, but the highest scores were for the HRR test. Poor visual acuity slightly decreased the accuracy of all tests. Our advice is to use the HRR test since this test also allows for evaluation of all three color axes and quantification of color defects.

28 February 2024 in Genetics in Medicine
Verified
Journal Article
Open access
JHJi Hoon Han
Ji Hoon Han
KRKim Rodenburg
Kim Rodenburg
THTamar Hayman
Tamar Hayman
GCGiacomo Calzetti
Giacomo Calzetti
KKKarolina Kaminska
Karolina Kaminska
CRCarlo Rivolta
Carlo Rivolta
Inherited retinal diseases (IRDs) are a group of monogenic conditions that can lead to progressive blindness. Their missing heritability is still considerable, due in part to the presence of disease genes that await molecular identification. The purpose of this work was to identify novel genetic associations with IRDs. Patients underwent a comprehensive ophthalmological evaluation using standard-of-care tests, such as detailed retinal imaging (macular OCT, short-wavelength fundus autofluorescence) and electrophysiological testing. Exome and genome sequencing, as well as computer-assisted data analysis were used for genotyping and detection of DNA variants. A minigene-driven splicing assay was performed to validate the deleterious effects of one of such variants. We identified 8 unrelated families from Hungary, the United States, Israel, and the Netherlands with members presenting with a form of autosomal recessive and nonsyndromic retinal degeneration, predominantly described as rod-cone dystrophy but also including cases of cone / cone-rod dystrophy. Age of disease onset was very variable, with some patients experiencing first symptoms during their fourth decade of life or later. Myopia greater than 5 diopters was present in 5 of 7 cases with available refractive data, and retinal detachment was reported in 2 cases. All ascertained patients carried biallelic loss-of-function variants in UBAP1L (HGNC: 40028), a gene with unknown function and with homologies to UBAP1, encoding a protein involved in ubiquitin metabolism. One of these pathogenic variants, the intronic NM_001163692.2:c.910-7G>A substitution, was identified in five unrelated families. Minigene-driven splicing assays in HEK293T cells confirmed that this DNA change is responsible for the creation of a new acceptor splice site, resulting in aberrant splicing. We identified UBAP1L as a novel IRD gene. Although its function is currently unknown, UBAP1L is almost exclusively expressed in photoreceptors and the retinal pigment epithelium, hence possibly explaining the link between pathogenic variants in this gene and an ocular phenotype.